Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018278
Filing Date
2025-06-26
Accepted
2025-06-26 16:30:20
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 form4-06262025_040608.html 4  
1 form4-06262025_040608.xml 4 3995
  Complete submission text file 0001415889-25-018278.txt   5418
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Baker Daniel G. (Reporting) CIK: 0002046802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 251080819